Amwell makes grant to new employee under inducement plan
06 Maio 2025 - 5:05PM
Amwell® (NYSE: AMWL), a leading technology-enabled care
platform provider, announced that on May 6, Amwell made a grant of
RSUs of 3,451 shares of its Class A common stock to one new
employee. The grant was offered as material inducement to the
employee’s employment with Amwell. The RSUs will vest as follows,
subject to the employee’s continued employment through the
applicable vesting date: 25% of the RSUs will vest upon the first
anniversary of the grant date (“Initial Vesting Date”), and the
remaining 75% of the RSUs will vest in equal pro rata increments
every three months thereafter (beginning on the first calendar day
of the month following the date that is three months following the
Initial Vesting Date) for three years until such RSUs are vested in
full.
The grants described in this press release were approved by the
Compensation Committee of the Amwell’s Board of Directors pursuant
to the Amwell’s Inducement Plan and made in reliance on the
employment inducement exemption under the NYSE’s Listed Company
Manual Rule 303A.08. Amwell is issuing this press release pursuant
to Rule 303A.08.
About Amwell Amwell offers payers and health
systems a single, comprehensive, technology-enabled care platform.
We use technology to provide patients with better access to more
convenient, affordable and effective care. The Amwell platform
includes software and services that power many clinical programs
from Amwell and our growing number of partners. Our platform allows
patients to experience unified, personalized and simple access to
diversified clinical programs across the care continuum. As more
people seek care online and more clinical programs become
available, we offer integrated, future-ready, consistent solutions.
The Amwell platform is proven, operating at a large scale, enabling
care for millions of patients and their sponsors while delivering
dependable outcomes. For almost two decades, Amwell has proudly
served some of the largest and most sophisticated healthcare
organizations in the U.S. and worldwide. For more information,
visit business.amwell.com or LinkedIn.
Media:Angela VogenPress@amwell.com
Investor: Sue DooleySue.Dooley@amwell.com
Notice of OwnershipAll materials contained
herein are the property of American Well Corporation and are
copyrighted under United States law and applicable international
copyright laws and treaty provisions. The materials contained
herein are not work product or "work for hire" on behalf of any
third party. The materials contained herein constitute the
confidential information of American Well Corporation, except for
specific data elements provided by third parties, which are the
confidential information of such third parties. The content
contained herein results from the application of American Well
proprietary processes, analytical frameworks, algorithms, business
methods, solution construction aids and templates, all of which are
and remain the property of American Well Corporation.
Trademark NoticeAll of the trademarks, service
marks and logos displayed on these materials (the "Trademark(s)")
are registered and unregistered trademarks of American Well
Corporation or third parties who have licensed their Trademarks to
American Well Corporation. Except as expressly stated in these
terms and conditions, you may not reproduce, display or otherwise
use any Trademark without first obtaining American Well
Corporation's written permission.
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Mai 2025 até Jun 2025
American Well (NYSE:AMWL)
Gráfico Histórico do Ativo
De Jun 2024 até Jun 2025